| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |